QLYS · Qualys, Inc.

Current Thesis

Qualys’ post-earnings recovery thesis requires a weekly close above the market’s 2026-08-28 close of $187.05 before a weekly close below $170 breaks the September support shelf. The operating case remains the revenue guidance increase announced on 2026-08-04; the next quarterly results must establish whether that improvement persists.

The measured change since the previous assessment is modest improvement: the adjusted close reached $174.96 on 2026-09-18, versus $171.65 on 2026-09-04, while the 14-day relative strength index (RSI) rose to 43.2 points from 39.1 points. Those observations establish a higher reference close, but the sample is too small to establish a durable recovery.

As an inference, the narrative is maturing — the 2026-08-05 analyst revision cluster has been followed by a Wedbush Neutral assessment recorded by Benzinga on 2026-09-11, while the 2026-09-18 close remains below the August reference. The earlier saturated characterization exceeds the available crowding evidence: current fund flows, retail participation and synchronized peer returns are missing. A weekly recovery above $187.05 accompanied by renewed operating acceleration would contradict the interpretation of moderating momentum. Benzinga analyst records

Bullish and bearish views on Qualys, Inc.

The model's bull view on Qualys, Inc. (QLYS), in brief: Reported growth supports the reset. Qualys reported Q2 revenue of $182.2 million, up 11% year over year, and a 34% operating margin under generally accepted accounting principles (GAAP) on 2026-08-04. These are measured operating results supporting the recovery case. Qualys Q2… The bear view: New coverage offers limited confirmation. Both cases follow in full.

Bull Case

• Reported growth supports the reset. Qualys reported Q2 revenue of $182.2 million, up 11% year over year, and a 34% operating margin under generally accepted accounting principles (GAAP) on 2026-08-04. These are measured operating results supporting the recovery case. Qualys Q2 results
• Guidance raised the operating hurdle. On 2026-08-04, management raised FY2026 revenue guidance to $732–738 million from $721–727 million and adjusted earnings per share guidance to $7.74–7.88 from $7.44–7.65. Q3 revenue guidance was $185.5–187.5 million; revenue at or below its lower endpoint would fail the continuation test. Qualys Q2 results
• September reference prices improved. The adjusted close increased from $171.65 on 2026-09-04 to $174.96 on 2026-09-18, according to the dated daily-bar observations. This supports only a tentative stabilization inference, invalidated by a weekly close below $170.

Bear Case

• New coverage offers limited confirmation. Benzinga’s 2026-09-11 record attributes a Neutral assessment and $175 analyst price target to Wedbush’s Steven Wahrhaftig. The market’s 2026-09-18 close was $174.96; that assessment supplies little separation between the observed price and Wedbush’s valuation. It also supersedes the earlier assertion that analyst activity stopped on 2026-08-05. Benzinga analyst records
• Insider selling continued during September. Chief executive Sumedh Thakar reported sales dated 2026-09-14 in a Form 4 filed on 2026-09-15. The filing identifies a Rule 10b5-1 trading plan adopted on 2026-02-27; the transaction is observable supply, but it does not establish a discretionary response to current-quarter demand. Thakar Form 4
• The earnings test remains unconfirmed. Qualys’ investor calendar, checked on 2026-09-20, lists no upcoming events. The estimated 2026-11-03 results date therefore remains an estimate, and the calendar provides no confirmed earnings catalyst within the next 30 days. Qualys events calendar

Setup & Price Structure

The 2026-09-18 adjusted close was $174.96, with a three-month price increase of 61.2% and RSI of 43.2 points. The same dated series reports a 52-week high of $195.88 and a 10.7% distance below that high. These measurements describe substantial earlier appreciation followed by a retreat; they do not identify who supplied the demand.

The $170 research shelf published on 2026-09-06 remains the thesis-break reference. The market’s $187.05 close on 2026-08-28 defines the recovery hurdle: a weekly close above $187.05 before invalidation constitutes the price case playing out. The intervening weekly-close sequence is missing, so the supplied endpoints cannot establish that the shelf held throughout September.

Crowding remains unmeasured. The 2026-09-11 Wedbush assessment and Thakar’s 2026-09-14 planned sales document analyst attention and insider supply, respectively; neither establishes crowded ownership. A current moving-average level, dated short-interest series and comparable volume history are unavailable. Benzinga analyst records, Thakar Form 4

Catalyst Calendar (next 30 days)

• 2026-09-30 — Fiscal Q3 ends. This is the accounting endpoint for the $185.5–187.5 million revenue guidance issued on 2026-08-04. Quarter end itself does not disclose the result, and the company calendar checked on 2026-09-20 lists no accompanying results event. Qualys Q2 guidance, Qualys events calendar
• ~2026-11-03, est. Q3 results. This later event is the operating test retained from the 2026-09-06 assessment, not a company-confirmed appointment. Revenue above the $187.5 million upper endpoint would support continuing acceleration; revenue at or below $185.5 million would break that fundamental interpretation. Qualys Q2 guidance, Qualys events calendar

What Would Change Our Mind

Loss of the September support shelf ends the recovery case: a weekly close below $170 is the gradeable price condition retained from the 2026-09-06 research note. The higher 2026-09-18 reference close does not justify moving that condition.

Operating confirmation requires the next report to extend the guidance increase announced on 2026-08-04. Q3 revenue at or below $185.5 million would invalidate the acceleration interpretation even if the price shelf survived. Conversely, revenue above $187.5 million alongside a weekly close above the market’s 2026-08-28 reference of $187.05 would establish both operating and price confirmation. Qualys Q2 guidance

Correlation Notes

Benzinga’s 2026-08-18 article, “5 Cybersecurity Stocks with More Upside Ahead,” framed Cybersecurity strength as a rotation associated with artificial-intelligence security demand. That is an attributed sector interpretation, not a measured correlation for Qualys.

This remains a single-company recovery case anchored to the 2026-08-04 guidance increase and the 2026-09-18 adjusted close. No synchronized peer-return sample accompanies those observations, so the evidence cannot establish sector leadership or dependence on a broader software rally. The published $170 weekly-close condition applies regardless of the sector explanation.